The authors also compared the levels of anti-GP2 antibodies in pouch patients to patients with UC (n = 7) and Crohn’s disease (n = 7) and reported that sera levels of anti-GP2 were similar, suggesting a similar pathophysiology in both conditions. This evidence concerns the gene GP2 and Crohn disease.